Debtor and Debtor-In-Possession as of March 18, 2013 Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash Flows from Operating Activities
Net income (loss)	$ (59,327)	$ 57,572
Reconciliation of net income (loss) to net cash provided by operating activities:
Gain on debt repurchases, net	0	(68,763)
Depreciation and amortization	89,487	103,751
Deferred income tax benefit	(1,746)	(2,787)
Provision for bad debts	6,514	11,037
Merger transaction and integration expenses	10,243	0
Stock-based compensation expense	670	1,064
Reorganization items, net	35,903	0
Other items, net	(9,997)	6,202
Changes in assets and liabilities:
Decrease in accounts receivable	42,124	45,570
Decrease in other assets	6,241	17,833
(Decrease) in accounts payable and accrued liabilities	(11,731)	(27,936)
(Decrease) in deferred revenue	(52,318)	(55,780)
(Decrease) in other non-current liabilities	(1,315)	(9,654)
Net cash provided by operating activities	54,748	78,109
Cash Flows from Investing Activities
Additions to fixed assets and computer software	(5,643)	(5,005)
Proceeds from sale of assets	0	20
Net cash used in investing activities	(5,643)	(4,985)
Cash Flows from Financing Activities
Debt repurchases and repayments	(81,599)	(213,743)
Debt issuance costs and other financing items, net	(515)	(1,979)
Decrease in checks not yet presented for payment	(312)	(140)
Net cash used in financing activities	(82,426)	(215,862)
Decrease in cash and cash equivalents	(33,321)	(142,738)
Cash and cash equivalents, beginning of period	172,040	257,939
Cash and cash equivalents, end of period	138,719	115,201
Supplemental Information:
Cash interest, net	36,792	42,198
Cash income taxes, net	(95)	3,018
Non-cash Financing Activities:
Reduction of debt from debt repurchases	0	(72,613)
Issuance of Dex One Senior Subordinated Notes in lieu of cash interest payments	$ 0	$ 10,500